HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tae Sung Kim Selected Research

Chemokines

1/2019SIRT3 promotes antimycobacterial defenses by coordinating mitochondrial and autophagic functions.
11/2009Analysis of the expression profiles of cytokines and cytokine-related genes during the progression of breast cancer growth in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tae Sung Kim Research Topics

Disease

49Neoplasms (Cancer)
02/2022 - 05/2002
19Inflammation (Inflammations)
03/2021 - 05/2002
18Leukemia
05/2016 - 10/2002
17Infections
02/2021 - 04/2005
11Breast Neoplasms (Breast Cancer)
01/2019 - 04/2004
9Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2017 - 06/2006
9Neoplasm Metastasis (Metastasis)
12/2014 - 06/2003
6Acute Promyelocytic Leukemia
11/2015 - 10/2006
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2017 - 07/2010
4Wounds and Injuries (Trauma)
12/2020 - 07/2002
4Autoimmune Diseases (Autoimmune Disease)
01/2020 - 06/2005
4Tuberculosis (Tuberculoses)
01/2019 - 09/2006
4Rheumatoid Arthritis
11/2017 - 10/2002
4Lung Diseases (Lung Disease)
10/2017 - 09/2006
4Melanoma (Melanoma, Malignant)
10/2016 - 06/2006
4Myeloid Leukemia (Leukemia, Myelocytic)
02/2008 - 10/2002
3Chronic Obstructive Pulmonary Disease (COPD)
02/2022 - 12/2016
3Papillary Thyroid Cancer
10/2021 - 03/2015
3Adenocarcinoma
10/2020 - 06/2009
3Bronchiectasis
10/2018 - 04/2005
3Communicable Diseases (Infectious Diseases)
06/2016 - 05/2002
3Septic Shock (Toxic Shock Syndrome)
07/2015 - 11/2011
3Necrosis
02/2015 - 01/2006
3Hypersensitivity (Allergy)
06/2012 - 04/2005
3Pulmonary Tuberculosis
05/2009 - 04/2004
3BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
02/2009 - 10/2006
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
07/2006 - 06/2003
2Pancreatic Neoplasms (Pancreatic Cancer)
02/2022 - 10/2020
2Blister (Bulla)
02/2022 - 01/2010
2Atopic Dermatitis (Atopic Eczema)
02/2021 - 05/2010
2Asthma (Bronchial Asthma)
01/2019 - 05/2002
2Adenocarcinoma of Lung
01/2019 - 12/2018
2Toxic Optic Neuropathy
07/2018 - 06/2015
2Fibrosis (Cirrhosis)
10/2017 - 10/2002
2Immune System Diseases (Immune Disorders)
11/2016 - 06/2012
2Thyroid Neoplasms (Thyroid Cancer)
03/2015 - 08/2010
2Anthrax
12/2014 - 01/2014
2Crohn Disease (Crohn's Disease)
07/2014 - 06/2011
2Vasculitis (Vasculitides)
07/2014 - 06/2011
2Residual Neoplasm
12/2013 - 03/2006
2Stomach Neoplasms (Stomach Cancer)
02/2013 - 06/2006

Drug/Important Bio-Agent (IBA)

15CytokinesIBA
11/2019 - 01/2006
13Proteins (Proteins, Gene)FDA Link
02/2022 - 04/2004
10Tretinoin (Retinoic Acid)FDA LinkGeneric
03/2014 - 10/2002
9DNA (Deoxyribonucleic Acid)IBA
01/2017 - 08/2003
8Interleukin-18 (Interleukin 18)IBA
02/2015 - 06/2006
8VaccinesIBA
01/2014 - 03/2006
7AntigensIBA
01/2014 - 01/2006
6Biological ProductsIBA
02/2022 - 05/2002
6InterleukinsIBA
01/2020 - 05/2002
6Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2019 - 06/2003
6Pharmaceutical PreparationsIBA
01/2017 - 09/2006
5Therapeutic UsesIBA
12/2020 - 05/2002
5Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA
11/2019 - 09/2011
5Interleukin-12 (IL 12)IBA
08/2013 - 05/2002
51,25-dihydroxyvitamin DIBA
02/2011 - 08/2003
5AcidsIBA
05/2009 - 04/2005
4Interleukin-4 (Interleukin 4)IBA
01/2017 - 03/2006
4Complementary DNA (cDNA)IBA
04/2008 - 08/2003
3Phosphotransferases (Kinase)IBA
03/2021 - 05/2006
3ErbB Receptors (EGF Receptor)IBA
10/2020 - 07/2010
3Biomarkers (Surrogate Marker)IBA
07/2019 - 01/2017
3MicroRNAs (MicroRNA)IBA
02/2017 - 06/2016
3LipidsIBA
01/2017 - 07/2013
3Immunoglobulin E (IgE)IBA
01/2017 - 04/2005
3LactonesIBA
11/2015 - 10/2002
3SesquiterpenesIBA
11/2015 - 10/2002
3Cytarabine (Cytosar-U)FDA LinkGeneric
07/2015 - 04/2008
3Virulence Factors (Pathogenicity Factors)IBA
12/2014 - 04/2008
3CeramidesIBA
07/2013 - 04/2006
3SantoninIBA
02/2011 - 01/2006
3AcetalsIBA
02/2011 - 01/2006
3AllergensIBA
05/2010 - 04/2005
3AlkaloidsIBA
08/2003 - 05/2002
2Peptides (Polypeptides)IBA
02/2021 - 01/2020
2LigandsIBA
10/2020 - 01/2019
2Immunoglobulin G (IgG)IBA
11/2019 - 01/2017
2Interleukin-10 (Interleukin 10)IBA
01/2019 - 08/2013
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2019 - 01/2017
2ChemokinesIBA
01/2019 - 11/2009
2Interleukin-1beta (Interleukin 1 beta)IBA
01/2019 - 08/2003
2Matrix Metalloproteinases (MMPs)IBA
01/2019 - 09/2009
2Interleukin-6 (Interleukin 6)IBA
01/2019 - 01/2018
2Indicators and Reagents (Reagents)IBA
10/2018 - 07/2015
2Interleukin-33IBA
11/2017 - 01/2017
2n-hexanal (hexanal)IBA
10/2017 - 12/2016
2Cadherins (E-Cadherin)IBA
10/2016 - 02/2013
2indirubinIBA
05/2016 - 10/2006
2Toll-Like Receptors (Toll-Like Receptor)IBA
07/2015 - 12/2014
2IodineIBA
03/2015 - 11/2012

Therapy/Procedure

26Therapeutics
02/2021 - 10/2002
7Drug Therapy (Chemotherapy)
01/2017 - 09/2010
4Immunotherapy
02/2022 - 01/2006
4Radiotherapy
01/2017 - 08/2010
3Decompression
02/2022 - 10/2008
3Aftercare (After-Treatment)
11/2019 - 10/2008
3Neoadjuvant Therapy
01/2019 - 01/2012
2Thyroidectomy
10/2021 - 08/2015
2Traction
10/2018 - 09/2012
2Nerve Block (Nerve Blocks)
09/2014 - 08/2011